Uploaded September 2021 | Updated November 2026, 1 day ago
Register to upcoming events
everythingals.org/events
Participate in our ALS Research
everythingals.org/research
Clenbuterol for ALS, Findings from an Open Label Trial with Dr. Richard Bedlack from Duke University.
Richard Bedlack M.D., Ph.D. is currently a Professor of Neurology at Duke University, and Director of the Duke ALS Clinic. He has won awards for teaching and for patient care, including: best neurology teacher at Duke; Health Care Hero; Strength, Hope, and Caring Award; America’s Best Doctors; the American Academy of Neurology's Kenneth M. Viste, Jr., MD, Patient Advocate of the Year Award, and the ALS Association's Rasmussen Award for ALS Patient Advocate of the Year.
Dr. Bedkack has also received research grants, participated in clinical trials, and published more than 130 articles. He currently leads the international ALSUntangled program, which utilizes social networking to investigate alternative and off-label treatment options for patients with ALS, and the ALS Reversals program which seeks to verify and understand cases of recovery from ALS in hopes of making them happen more often.
DO NOT Miss Another Event, Subscribe to our Channel:
youtube.com/c/everythingals
Register to upcoming events
everythingals.org/events
Participate in our ALS Research
everythingals.org/research
Clenbuterol for ALS, Findings from an Open Label Trial with Dr. Richard Bedlack from Duke University.
Richard Bedlack M.D., Ph.D. is currently a Professor of Neurology at Duke University, and Director of the Duke ALS Clinic. He has won awards for teaching and for patient care, including: best neurology teacher at Duke; Health Care Hero; Strength, Hope, and Caring Award; America’s Best Doctors; the American Academy of Neurology's Kenneth M. Viste, Jr., MD, Patient Advocate of the Year Award, and the ALS Association's Rasmussen Award for ALS Patient Advocate of the Year.
Dr. Bedkack has also received research grants, participated in clinical trials, and published more than 130 articles. He currently leads the international ALSUntangled program, which utilizes social networking to investigate alternative and off-label treatment options for patients with ALS, and the ALS Reversals program which seeks to verify and understand cases of recovery from ALS in hopes of making them happen more often.
DO NOT Miss Another Event, Subscribe to our Channel:
youtube.com/c/everythingals





![#ExpertTalk: Targeting an Endogenous Retrovirus as a Therapeutic Approach to ALS
Welcome to another enlightening #experttalk by the EverythingALS, where we delve into cutting-edge research and innovative approaches to combating #ALS (Amyotrophic Lateral Sclerosis).
This discussion dives into the science behind endogenous retroviruses (ERVs), their role in neurodegenerative diseases, and how understanding them could pave the way for innovative treatments for ALS.
🕒 Timestamps
0:00 – Introduction
Meet the speakers and an overview of the session.
3:45 – Understanding Endogenous Retroviruses
What are ERVs, and why are they significant in neurodegenerative diseases?
10:20 – The Role of ERVs in ALS Pathology
How ERVs influence ALS development and progression.
20:15 – Innovative Therapeutic Strategies
Exploring cutting-edge research and treatment possibilities targeting ERVs.
30:50 – Q&A with the Experts
Addressing audience questions and discussing the future of ALS therapies.
40:25 – Closing Remarks
Final insights and takeaways from the session.
👩🔬 About EverythingALS:
EverythingALS is a patient-focused nonprofit organization dedicated to accelerating the discovery of treatments and a cure for ALS through collaboration, innovation, and empowering patients and researchers.
📩 Stay Connected:
Subscribe to our channel and turn on notifications to stay updated on the latest expert talks and research breakthroughs in ALS.
💡 Don’t forget to:
✅ Like this video if you found it helpful!
✅ Subscribe to our channel for more expert talks and updates: [EverythingALS YouTube Channel].
✅ Share this video to spread awareness and support ALS research.
📌 For more resources and to participate in EverythingALS initiatives, visit: everythingals.org
#ALS #EndogenousRetrovirus #ALSResearch #TherapeuticApproach #EverythingALS #Neurodegeneration #ExpertTalk: Targeting an Endogenous Retrovirus as a Therapeutic Approach to ALS](https://i.ytimg.com/vi/5VDgqCW8eOw/mqdefault.jpg)




